Clene (CLNN) Price to Sales (2020 - 2026)
Clene (CLNN) posted Price to Sales of 874.6 for Q2 2026, up 5.74% on a QoQ basis from 827.13 in Q4 2025, and down 36.17% year-over-year from 1370.25 in Q2 2025.
Analysis
Clene (CLNN) Price to Sales (2020 - 2026) Analysis & Trends
Clene has reported Price to Sales for 7 years, with the latest figure at 874.6 in Q2 2026.
- On a quarterly basis, Price to Sales fell 36.17% year-over-year to 874.6 in Q2 2026; TTM through Jun 2026 was 376.62, a 191.15% increase from a year earlier, with the FY2025 full-year figure at 318.45, up 153.54% from the prior year.
- Price to Sales was 874.6 for Q2 2026 at Clene, up from 827.13 in the prior quarter.
- The five-year high for Price to Sales was 8306.38 in Q1 2022, with the low at 185.19 in Q4 2023.
- Average Price to Sales over 5 years is 1512.29, with a median of 756.53 recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Price to Sales tumbled 93.84% in 2023, then jumped 1035.63% in 2025.
- Over 5 years, Price to Sales stood at 319.49 in 2022, then plunged by 42.04% to 185.19 in 2023, then soared by 154.9% to 472.04 in 2024, then soared by 75.23% to 827.13 in 2025, then climbed by 5.74% to 874.6 in 2026.
- The last three Price to Sales figures came in at 874.6 (Q2 2026), 827.13 (Q4 2025), and 4108.42 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 874.60 |
| Dec 31, 2025 | 827.13 |
| Sep 30, 2025 | 4,108.42 |
| Jun 30, 2025 | 1,370.25 |
| Mar 31, 2025 | 329.59 |
| Dec 31, 2024 | 472.04 |
| Sep 30, 2024 | 361.77 |
| Jun 30, 2024 | 509.03 |
| Mar 31, 2024 | 756.53 |
| Dec 31, 2023 | 185.19 |
| Sep 30, 2023 | 594.50 |
| Jun 30, 2023 | 281.50 |
| Mar 31, 2023 | 823.60 |
| Dec 31, 2022 | 319.49 |
| Sep 30, 2022 | 1,022.51 |
| Jun 30, 2022 | 4,566.38 |
| Mar 31, 2022 | 8,306.38 |
| Dec 31, 2021 | 1,283.82 |
| Sep 30, 2021 | 3,860.63 |
| Jun 30, 2021 | 3,393.34 |